Immuno-oncology

RSS

Herceptin: promising phase III results reported at ASCO

May 20, 1998

No Comments

Neurocrine Biosciences initiates clinical-stage development of IL-4 fusion toxin

May 19, 1998

No Comments

Leuvectin proceeds to phase II for renal cell carcinoma

May 19, 1998

No Comments

Antigenics receives patent protection for HSP-based cancer immunotherapy

May 15, 1998

No Comments

Bexxar: encouraging interim phase III data reported

May 14, 1998

No Comments

DAB389IL-7, a novel fusion protein for the specific elimination of IL-7 receptor-positive cells

May 12, 1998

No Comments

Patient enrollment begins for U.S. trial of Maxamine in malignant melanoma

May 11, 1998

No Comments

Multikine clinical trials update

May 11, 1998

No Comments

Genentech files for marketing approval of Herceptin

May 5, 1998

No Comments

Biomira initiates bridging study of Theratope cancer vaccine

May 4, 1998

No Comments